Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP703949.RA_5l6SUyLN_Qofpvgzu3Mfzr7vCoFnNKCo_6mVNEnKqQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP703949.RA_5l6SUyLN_Qofpvgzu3Mfzr7vCoFnNKCo_6mVNEnKqQ130_assertion type Assertion NP703949.RA_5l6SUyLN_Qofpvgzu3Mfzr7vCoFnNKCo_6mVNEnKqQ130_head.
- NP703949.RA_5l6SUyLN_Qofpvgzu3Mfzr7vCoFnNKCo_6mVNEnKqQ130_assertion description "[Although triethylenemelamine is no longer prescribed, our findings warrant further follow-up to investigate potential SMN risks associated with current chemotherapies used for Rb.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP703949.RA_5l6SUyLN_Qofpvgzu3Mfzr7vCoFnNKCo_6mVNEnKqQ130_provenance.
- NP703949.RA_5l6SUyLN_Qofpvgzu3Mfzr7vCoFnNKCo_6mVNEnKqQ130_assertion evidence source_evidence_literature NP703949.RA_5l6SUyLN_Qofpvgzu3Mfzr7vCoFnNKCo_6mVNEnKqQ130_provenance.
- NP703949.RA_5l6SUyLN_Qofpvgzu3Mfzr7vCoFnNKCo_6mVNEnKqQ130_assertion SIO_000772 25185089 NP703949.RA_5l6SUyLN_Qofpvgzu3Mfzr7vCoFnNKCo_6mVNEnKqQ130_provenance.
- NP703949.RA_5l6SUyLN_Qofpvgzu3Mfzr7vCoFnNKCo_6mVNEnKqQ130_assertion wasDerivedFrom befree-20150227 NP703949.RA_5l6SUyLN_Qofpvgzu3Mfzr7vCoFnNKCo_6mVNEnKqQ130_provenance.
- NP703949.RA_5l6SUyLN_Qofpvgzu3Mfzr7vCoFnNKCo_6mVNEnKqQ130_assertion wasGeneratedBy ECO_0000203 NP703949.RA_5l6SUyLN_Qofpvgzu3Mfzr7vCoFnNKCo_6mVNEnKqQ130_provenance.